This job has expired

You will need to login before you can apply for a job.

Region Manager, Midwest

Corcept Therapeutics
Chicago, Illinois, United States
Start date
Jan 19, 2023

Job Details

Corcept is engaged in the discovery and development of drugs that treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol. Since 2012, we have marketed Korlym® for the treatment of patients suffering from Cushing’s syndrome, a life-threatening orphan disorder caused by excess cortisol activity.

In addition to our commercial product, Korlym, we have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators.  Lead compounds are in Phase 2 and Phase 3 trials for the treatment of patients with Cushing’s syndrome, advanced ovarian cancer, castration-resistant prostate cancer, weight gain caused by antipsychotic medications and non-alcoholic steatohepatitis (“NASH”).  We are about to start a Phase 2 trial in patients with amyotrophic lateral sclerosis (“ALS”).

In 2021, we generated revenue of $366 million and net income of $112 million.

The RM will manage a team of Clinical Specialists (CS) and provide consistent direction regarding the execution of sales and marketing strategies for the Midwest region.


  • Formulate sales strategies and analyze performance within the region
  • Fully engage with key customers by developing and implementing strategies that support sales growth
  • Provide on-going coaching and development of CS team
  • Develop and maintain customer relationships with key executives and decision makers in all key accounts
  • Participate in and contribute to commercial team planning sessions as requested, representing the needs of customers and the sales team and driving business building plans of the organization
  • Act as local liaison and collaborator, building consensus on strategies and tactics that drive business results
  • Operate within compliance guidelines at all times

Preferred Skills, Qualifications and Technical Proficiencies:

  • Proven success in leading a sales team within a large geography
  • Experience in endocrinology, orphan disease, or other specialized markets a plus
  • Strong clinical acumen
  • Ability to analyze sales and other relevant market data to formulate strategic plans
  • Strong ability to collaborate and work cross-functionally
  • Required to travel by car and plane at least 80% of the time

Preferred Education and Experience:

  • Must maintain a driving record in accordance with Corcept vehicle policy
  • Master’s Degree in a life science or related field or equivalent experience
  • At least 10 years project management experience in drug development in the pharmaceutical industry, including Phases 1-3, regulatory filings and product launch
  • PMP or other Project Management Institute certification


The pay range that the Company reasonably expects to pay for this position is $190,000 - $210,000; the pay ultimately offered may vary based on legitimate considerations, including job-related knowledge, skills, experience, and education.  An annual cash bonus and equity grants may be provided as part of the overall compensation package, in addition to a full range of financial, health and wellness benefits, dependent on the position offered.

Applicants must be currently authorized to work in the United States on a full-time basis.

If you are based in California, we encourage you to read this important information for California residents linked here.

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at:

Corcept is an Equal Opportunity Employer


Corcept is leading the discovery and development of drugs that modulate the effects of cortisol.
Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases.  Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998.
Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity.  To support this mission, Corcept collaborates with numerous basic scientists and clinical researchers to find better ways to improve patient lives.
Through our collaborations with researchers around the world, more than 30 studies are underway to investigate the potential benefits GR antagonists may have in the treatment of serious and life-threatening diseases driven by cortisol dysregulation.

Stock Symbol: CORT

Find Us
149 Commonwealth Drive
Menlo Park

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert